A detailed history of Cetera Investment Advisers transactions in Opko Health, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 65,695 shares of OPK stock, worth $79,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,695
Holding current value
$79,490
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024

BUY
$0.87 - $1.57 $57,154 - $103,141
65,695 New
65,695 $78,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $2.17 $7,665 - $11,088
-5,110 Reduced 29.87%
12,000 $19,000
Q2 2022

Aug 11, 2022

BUY
$2.33 - $3.61 $3,495 - $5,415
1,500 Added 9.61%
17,110 $43,000
Q2 2021

Aug 13, 2021

BUY
$3.33 - $4.55 $1,665 - $2,275
500 Added 3.31%
15,610 $63,000
Q1 2021

May 17, 2021

SELL
$4.19 - $5.99 $3,561 - $5,091
-850 Reduced 5.33%
15,110 $65,000
Q4 2020

Feb 17, 2021

BUY
$3.27 - $4.87 $52,189 - $77,725
15,960 New
15,960 $63,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $934M
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.